Ani Pharmaceuticals (ANIP) Return on Capital Employed: 2012-2025
Historic Return on Capital Employed for Ani Pharmaceuticals (ANIP) over the last 14 years, with Sep 2025 value amounting to 0.07%.
- Ani Pharmaceuticals' Return on Capital Employed rose 5.00% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 5.00%. This contributed to the annual value of 0.00% for FY2024, which is 7.00% down from last year.
- Per Ani Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.07% for Q3 2025, which was up 363.34% from 0.01% recorded in Q2 2025.
- In the past 5 years, Ani Pharmaceuticals' Return on Capital Employed registered a high of 0.07% during Q1 2024, and its lowest value of -0.09% during Q3 2022.
- Its 3-year average for Return on Capital Employed is 0.03%, with a median of 0.03% in 2023.
- In the last 5 years, Ani Pharmaceuticals' Return on Capital Employed declined by 8bps in 2022 and then increased by 15bps in 2023.
- Quarterly analysis of 5 years shows Ani Pharmaceuticals' Return on Capital Employed stood at -0.07% in 2021, then rose by 2bps to -0.05% in 2022, then grew by 12bps to 0.06% in 2023, then declined by 6bps to 0.00% in 2024, then increased by 5bps to 0.07% in 2025.
- Its Return on Capital Employed stands at 0.07% for Q3 2025, versus 0.01% for Q2 2025 and 0.01% for Q1 2025.